Status:
TERMINATED
Scandinavian Intensive Care Unit (ICU) Glutamine Study
Lead Sponsor:
Scandinavian Critical Care Trials Group
Conditions:
ICU Patients
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
This is a prospective double-blinded placebo-controlled block randomized study in intensive care patients comparing intravenous glutamine supplementation to placebo. The hypothesis is an improvement o...
Detailed Description
This is a prospective double-blinded placebo-controlled block randomised study in intensive care patients comparing intravenous glutamine supplementation (0.285 g/kg body weight/24 h) to placebo. Incl...
Eligibility Criteria
Inclusion
- admission to the ICU
- decision to give the patient full nutrition
- APACHE II score \> 10 at admission
- age 18-85 years
Exclusion
- readmission to the ICU after a previous ICU-stay in which the patient has been included into the study
- subjects with any condition which in the opinion of the attending physician makes the subject unsuitable for inclusion
- no informed consent
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2009
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00922714
Start Date
October 1 2003
End Date
August 1 2009
Last Update
June 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intensive Care Unit, Karolinska University Hospital Huddinge
Stockholm, Sweden, 14186